Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > as you all know, even the spammers
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(22)
•••
Comment by 4Justiceon Oct 03, 2019 6:24pm
193 Views
Post# 30194122

RE:RE:RE:RE:as you all know, even the spammers

RE:RE:RE:RE:as you all know, even the spammersI do not want to bother you but considering that the "Rights" reported $ 38 million to $ 0.015 per share. According to that...

SALP owns 73.64%
CONSONNANCE 14.42%
OTHERS 11.94%

Others include the RSU (restricted share unit) and options granted by the company to the management.

We are close to the official vote of the shareholders for the change of name of the company.

SALP and CONS are the only ones who voted.

I was there...in the lobby!



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities